Product Information
GUAIFENESIN-PSE ER 600-60 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.3841 per EA under NDC 55111079841. Its NADAC has been published 281 times since May 19, 2021.
FDA first approved this application on Dec 29, 2017.
Strength
600; 60 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111079841
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208369FDA Approved
12/29/2017
On Market Since
12/29/2017
Pharmacological Classes
Price Statistics
The NADAC for GUAIFENESIN-PSE ER 600-60 MG has been published 281 times since May 19, 2021, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3841 per EA |
|---|---|
| All-time high | $0.4832 (Apr 12, 2023) |
| All-time low | $0.2640 (Jun 18, 2025) |
| 52-week high | $0.3891 |
| 52-week low | $0.3056 |
| Median price | $0.3872 |
| Average price | $0.3869 |
| Largest weekly change | +23.6% (Sep 18, 2024) |
| Weeks tracked | 281 |
| Tracking since | May 19, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin and Pseudoephedrine HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUAIFENESIN-PSE ER 600-60 MG?
The current National Average Drug Acquisition Cost (NADAC) for GUAIFENESIN-PSE ER 600-60 MG, manufactured by Dr. Reddy's Laboratories Inc., is $0.3841 per EA (NDC 55111079841), effective Sep 30, 2026.
How has the price of GUAIFENESIN-PSE ER 600-60 MG changed over time?
Over the history we have for it, the NADAC for GUAIFENESIN-PSE ER 600-60 MG has declined 9.3%. It has been tracked across 281 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for GUAIFENESIN-PSE ER 600-60 MG?
Since May 19, 2021, the NADAC for GUAIFENESIN-PSE ER 600-60 MG has ranged from a low of $0.2640 (Jun 18, 2025) to a high of $0.4832 (Apr 12, 2023), with a median of $0.3872 per EA.
Are there cheaper alternatives to GUAIFENESIN-PSE ER 600-60 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FT MUCUS RELIEF D ER 600-60 MG, is $0.2954 per EA — about 23% below GUAIFENESIN-PSE ER 600-60 MG.
Who manufactures GUAIFENESIN-PSE ER 600-60 MG?
GUAIFENESIN-PSE ER 600-60 MG (NDC 55111079841) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.